Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion

Experimental and Therapeutic Medicine

Volumn 9, Issue 5, 2015, Pages 1757-1762

  Tan, Feng ^a   Fu, Wenjun ^b   Cheng, Nanfang ^a   Meng, Di ^a   Gu, Yong ^c  

^a Foshan Hospital of Traditional Chinese Medicine   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Cerebral ischemia; Ligustrazine; Tetramethylpyrazine; Tight junction

Indexed keywords

CLAUDIN 5; GELATINASE B; OCCLUDIN; TETRAMETHYLPYRAZINE; TIGHT JUNCTION PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; WATER CONTENT; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 84925047874     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2365     Document Type: Article

References (25)

1. Gu Y, Dee CM and Shen J: Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front Biosci (Schol Ed) 3: 1216-1231, 2011.
2. Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401, 2011.
3. Gu Y, Chen J and Shen J: Herbal medicines for ischemic stroke: Combating inflammation as therapeutic targets. J Neuroimmune Pharmacol 9: 313-339, 2014.
4. Obermeier B, Daneman R and Ransohoff RM: Development, maintenance and disruption of the blood-brain barrier. Nat Med 19: 1584-1596, 2013.
5. Han JZ, Sun J, Zhu QG, Liu JY, Hu JH and Chen F: A modified LC-MS/MS method for determination of tetramethylpyrazine in microdialysis samples and calibration of home-made linear probes. Biomed Chromatogr 26: 1276-1281, 2012.
6. Chun-sheng L, Hsiao-meng Y, Yun-hsiang H, Chun P and Chi-fen S: Radix Salviae Miltiorrhizae and Rhizoma Ligustici Wallichii in coronary heart disease. Chin Med J (Engl) 4: 43-46, 1978.
7. Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, Hu S, Gong G and Chen SY: Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/reperfusion injury in rats. Neurosci Lett 449: 24-27, 2009.
8. Kao TK, Ou YC, Kuo JS, Chen WY, Liao SL, Wu CW, Chen CJ, Ling NN, Zhang YH and Peng WH: Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int 48: 166-176, 2006.
9. Xiao X, Liu Y, Qi C, Qiu F, Chen X, Zhang J and Yang P: Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia. Neurol Res 32: 547-555, 2010.
10. Liao SL, Kao TK, Chen WY, Lin YS, Chen SY, Raung SL, Wu CW, Lu HC and Chen CJ: Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett 372: 40-45, 2004.
11. Kao TK, Chang CY, Ou YC, Chen WY, Kuan YH, Pan HC, Liao SL, Li GZ and Chen CJ: Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp Neurol 247: 188-201, 2013.
12. Shih YH, Wu SL, Chiou WF, Ku HH, Ko TL and Fu YS: Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture. Neuroreport 13: 515-519, 2002.
13. Li SY, Jia YH, Sun WG, Tang Y, An GS, Ni JH and Jia HT: Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus. Free Radic Biol Med 48: 597-608, 2010.
14. Lu C, Zhang J, Shi X, Miao S, Bi L, Zhang S, Yang Q, Zhou X, Zhang M, Xie Y, et al: Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP. Int J Biol Sci 10: 350-357, 2014.
15. Leng YF, Gao XM, Wang SX and Xing YH: Effects of tetramethylpyrazine on neuronal apoptosis in the superficial dorsal horn in a rat model of neuropathic pain. Am J Chin Med 40: 1229-1239, 2012.
16. Fan LH, Wang KZ, Cheng B, Wang CS and Dang XQ: Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci 7: 48, 2006.
17. Feng L, Ke N, Cheng F, Guo Y, Li S, Li Q and Li Y: The protective mechanism of ligustrazine against renal ischemia/reperfusion injury. J Surg Res 166: 298-305, 2011.
18. Chang Y, Hsiao G, Chen SH, Chen YC, Lin JH, Lin KH, Chou DS and Sheu JR: Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol Sin 28: 327-333, 2007.
19. Li XY, He JL, Liu HT, Li WM and Yu C: Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways. J Ethnopharmacol 125: 83-89, 2009.
20. Gu Y, Zheng G, Xu M, et al: Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem 120: 147-156, 2012.
21. Yu F, Kamada H, Niizuma K, Endo H and Chan PH: Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J Neurotrauma 25: 184-195, 2008.
22. Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, Prestopnik J, Wills J and Rosenberg GA: Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke 42: 1345-1350, 2011.
23. Vorbrodt AW and Dobrogowska DH: Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: Electron microscopist's view. Brain Res Brain Res Rev 42: 221-242, 2003.
24. Sandoval KE and Witt KA: Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 32: 200-219, 2008.
25. Krizbai IA and Deli MA: Signalling pathways regulating the tight junction permeability in the blood-brain barrier. Cell Mol Biol (Noisy-le-grand) 49: 23-31, 2003.